TONIX PHARMACEUTICALS
Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring, and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonix’s portfolio is primarily composed of the central nervous system (CNS) and immunology product candidates. The CNS portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions.
TONIX PHARMACEUTICALS
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2007-11-16
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.tonixpharma.com
Total Employee:
11+
Status:
Active
Contact:
212-980-9155
Email Addresses:
[email protected]
Total Funding:
257.84 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Font Awesome
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Broadfin Capital
Broadfin Capital investment in Post-IPO Equity - Tonix Pharmaceuticals
Sabby Management
Sabby Management investment in Post-IPO Equity - Tonix Pharmaceuticals
Deerfield
Deerfield investment in Post-IPO Equity - Tonix Pharmaceuticals
Technology Partners
Technology Partners investment in Post-IPO Equity - Tonix Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-09 | Tonix Pharmaceuticals Announces Appointment of Jeffrey Rosenfeld, Ph.D., as Executive Director, Genomics and Bioinformatics |
Official Site Inspections
http://www.tonixpharma.com Semrush global rank: 1.74 M Semrush visits lastest month: 13.64 K
- Host name: gra.graphicainc.com
- IP address: 162.241.142.33
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Tonix Pharmaceuticals"
About - Tonix Pharmaceuticals
Our Mission, Vision, and Core Values Our Mission is to improve population health by inventing and developing innovative therapies and vaccines, through broad in-house capabilities and …See details»
Tonix Pharmaceuticals - Wikipedia
Since its formation in 2011, Tonix Pharmaceuticals has developed therapeutics for patients with chronic conditions. Fibromyalgia is a medical condition characterized by chronic widespread pain and a heightened pain response to pressure. Other symptoms include tiredness to a degree that normal activities are affected, sleep problems and troubles with memory. Some people also report restless legs syndromeSee details»
Tonix Pharmaceuticals Holding Corp. (TNXP)
Dec 3, 2024 Company. Tonix Pharmaceuticals Holding Corp. 26 Main Street Suite 101 Chatham, NJ 07928 T: 862-799-8599See details»
Leadership - Tonix Pharmaceuticals
Tonix is led by an executive team with significant industry experience in drug development. The expertise and relationships of our passionate leadership team make Tonix Pharmaceuticals’ …See details»
Tonix Pharmaceuticals Announces Expansion of Leadership Team …
Dec 3, 2024 This press release and further information about Tonix can be found at www.tonixpharma.com. Forward Looking Statements. Certain statements in this press release …See details»
TONIX PHARMACEUTICALS HOLDING CORP. - Crunchbase
Contact Email [email protected] Phone Number (862)-799-9155 Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring, and developing …See details»
Tonix Pharmaceuticals Holding - Overview, News & Similar
Jun 17, 2024 Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering CHATHAM, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding …See details»
Working at Tonix Pharmaceuticals - Zippia
Mar 14, 2024 www.tonixpharma.com. Organization Type. Public. Social Media. Tonix Pharmaceuticals Holding Corp., a development stage specialty pharmaceutical company, …See details»
Press Releases :: Tonix Pharmaceuticals Holding Corp. (TNXP)
Dec 3, 2024 Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate …See details»
Careers - Tonix Pharmaceuticals
Please send your resume and cover letter to [email protected] and include the position title in the subject of the email. Tonix provides equal employment opportunities (EEO) to all …See details»
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine …
Nov 1, 2024 In September 2024, Tonix announced that the World Health Organization’s (WHO’s) preferred target product profile (TPP), released at the WHO sponsored Mpox …See details»
Tonix Pharmaceuticals Announces Transition to Fully Integrated ...
Mar 19, 2024 “Tonix will become a fully integrated biopharmaceutical company with a mission of developing and marketing innovative, high-value therapeutics,” said Seth Lederman, M.D., …See details»
Tonix Pharmaceuticals - Facebook
Tonix Pharmaceuticals. 1,687 likes · 5 talking about this. Tonix Pharmaceuticals strives to be a leader in providing novel drug therapies and vaccines to...See details»
Therapeutic Areas Overview - Tonix Pharmaceuticals
Therapeutic Areas Tonix Pharmaceuticals is dedicated to advancing the science to improve patient care and public health.We are developing novel treatments across a range of …See details»
News & Events - Tonix Pharmaceuticals Holding Corp.
Aug 16, 2024 World Health Organization (WHO) has declared spread of mpox in multiple African countries a public health emergency of international concern (PHEIC) 1. ... This press release …See details»
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine …
Nov 1, 2024 New data show tolerability and no evidence of spreading to blood or tissues even at high doses of Tonix’s attenuated live-virus, minimally replicating vaccine candidate TNX-801 in ...See details»
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial …
Nov 12, 2024 [email protected] (862) 904-8182. Peter Vozzo ICR Healthcare [email protected] (443) 213-0505. Media Contact. Ray Jordan Putnam Insights …See details»
Tonix Pharmaceuticals Holding Corp (TNXP): Tonix …
4 days ago The World Health Organization (WHO) previously announced the growing number of mpox cases constitutes a public health emergency of international concern (PHEIC), with …See details»
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public …
Jun 28, 2024 This press release and further information about Tonix can be found at www.tonixpharma.com. Forward Looking Statements Certain statements in this press release …See details»